BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31883552)

  • 1.
    Grisoni F; Schneider G
    Chimia (Aarau); 2019 Dec; 73(12):1006-1011. PubMed ID: 31883552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generative Recurrent Networks for De Novo Drug Design.
    Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.
    Lin E; Lin CH; Lane HY
    J Chem Inf Model; 2022 Feb; 62(4):761-774. PubMed ID: 35128926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.
    Mouchlis VD; Afantitis A; Serra A; Fratello M; Papadiamantis AG; Aidinis V; Lynch I; Greco D; Melagraki G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinforced Adversarial Neural Computer for de Novo Molecular Design.
    Putin E; Asadulaev A; Ivanenkov Y; Aladinskiy V; Sanchez-Lengeling B; Aspuru-Guzik A; Zhavoronkov A
    J Chem Inf Model; 2018 Jun; 58(6):1194-1204. PubMed ID: 29762023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular
    Lin E; Lin CH; Lane HY
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32708785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo Molecular Design with Chemical Language Models.
    Grisoni F; Schneider G
    Methods Mol Biol; 2022; 2390():207-232. PubMed ID: 34731471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Reinforcement Learning for Multiparameter Optimization in
    Ståhl N; Falkman G; Karlsson A; Mathiason G; Boström J
    J Chem Inf Model; 2019 Jul; 59(7):3166-3176. PubMed ID: 31273995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
    D'Souza S; Kv P; Balaji S
    Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning for molecular generation.
    Xu Y; Lin K; Wang S; Wang L; Cai C; Song C; Lai L; Pei J
    Future Med Chem; 2019 Mar; 11(6):567-597. PubMed ID: 30698019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has Artificial Intelligence Impacted Drug Discovery?
    Patronov A; Papadopoulos K; Engkvist O
    Methods Mol Biol; 2022; 2390():153-176. PubMed ID: 34731468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo molecular design and generative models.
    Meyers J; Fabian B; Brown N
    Drug Discov Today; 2021 Nov; 26(11):2707-2715. PubMed ID: 34082136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graph-based generative models for de Novo drug design.
    Xia X; Hu J; Wang Y; Zhang L; Liu Z
    Drug Discov Today Technol; 2019 Dec; 32-33():45-53. PubMed ID: 33386094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generative chemistry: drug discovery with deep learning generative models.
    Bian Y; Xie XQ
    J Mol Model; 2021 Feb; 27(3):71. PubMed ID: 33543405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating and screening de novo compounds against given targets using ultrafast deep learning models as core components.
    Zhang H; Saravanan KM; Yang Y; Wei Y; Yi P; Zhang JZH
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35724626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Intelligent Deep Learning Molecular Generative Modeling of Scaffold-Focused and Cannabinoid CB2 Target-Specific Small-Molecule Sublibraries.
    Bian Y; Xie XQ
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generative Deep Learning for Targeted Compound Design.
    Sousa T; Correia J; Pereira V; Rocha M
    J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.